LB Pharmaceuticals 双相抑郁症II期Illuminate-1试验顶线数据预计于2028年第一季度公布

美股速递
Jul 22

LB Pharmaceuticals Inc 宣布,其针对双相抑郁症的II期临床试验Illuminate-1的顶线数据,预计将在2028年第一季度获得。这一关键时间点的披露,将有助于市场评估该药物候选品的临床潜力与未来开发前景。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10